Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
BAJAJHCARE | NSE
-16.00
-4.01%
Healthcare
Drug Manufacturers-Specialty & Generic
31/03/2024
18/09/2024
383.15
400.00
403.65
381.00
Bajaj HealthCare Limited a pharmaceutical company develops manufactures and supplies amino acids nutritional supplements and active pharmaceutical ingredients (APIs) for pharmaceutical nutraceuticals and food industries in India and internationally. The company's product portfolio consists of various APIs in the therapeutic categories of anti-diabetic antibiotic antiviral antiplatelet antifungal antihelmintic iron-chelating agent anticonvulsant growth stimulant non-steroidal anti-inflammatory drugs antihypertensive anthelmintics anti-asthmatic antioxidant urinary tract infection anti-histamine weight reducing venous disease antimalarial vitamin c disinfectant/ antiseptic stimulant anticonvulsant lipotropic agents nootropic vasoprotective/ antihemorrhagic cardiovascular agents food supplements anti-anemic amino acids antiasthmatic / bronchodilator nutritional supplement and minerals. It also provides formulations in the form of tablets capsules and oral powder as well as intermediates and impurities. In addition the company exports its products. Bajaj HealthCare Limited was incorporated in 1993 and is based in Thane India.
View LessLow Market Beta (-0.4 to 0.8)
Negative Momentum (Declining Price)
Weakness based on declining price with high volume
Price Below SMA10D
Microcap (<300M USD)
High Debt to Equity (> 0.75)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
43.1%1 month
34.3%3 months
47.8%6 months
39.1%-
-
3.89
1.20
0.43
32.20
2.98
-
834.83M
10.70B
127.96M
0.26
13.44
-79.50
1.90
-4.44
-
-
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
42.30
Range1M
58.40
Range3M
116.70
Rel. volume
1.60
Price X volume
160.07M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Nectar Lifesciences Limited | NECLIFE | Drug Manufacturers-Specialty & Generic | 46.62 | 10.75B | -2.59% | 201.62 | 59.44% |
Jagsonpal Pharmaceuticals Limited | JAGSNPHARM | Drug Manufacturers-Specialty & Generic | 405.85 | 10.74B | -1.04% | 53.99 | 4.77% |
Albert David Ltd | ALBERTDAVD | Drug Manufacturers-Specialty & Generic | 1479.35 | 8.44B | -0.14% | 10.74 | 0.87% |
Wanbury Limited | WANBURY | Drug Manufacturers-Specialty & Generic | 253.35 | 8.30B | -1.11% | 16.51 | 416.89% |
Ind-Swift Laboratories Limited | INDSWFTLAB | Drug Manufacturers-Specialty & Generic | 137.79 | 8.14B | -1.82% | 2.10 | 1.78% |
Kilitch Drugs (India) Limited | KILITCH | Drug Manufacturers-Specialty & Generic | 370.4 | 5.99B | -1.71% | 50.24 | 17.95% |
Medicamen Biotech Limited | MEDICAMEQ | Drug Manufacturers-Specialty & Generic | 463.15 | 5.84B | -2.80% | 72.99 | 15.37% |
Zim Laboratories Limited | ZIMLAB | Drug Manufacturers-Specialty & Generic | 112.64 | 5.52B | -0.58% | 31.56 | 45.58% |
Venus Remedies Limited | VENUSREM | Drug Manufacturers-Specialty & Generic | 347.15 | 4.67B | -1.00% | 17.16 | 8.48% |
Brooks Laboratories Limited | BROOKS | Drug Manufacturers-Specialty & Generic | 156.7 | 4.11B | 0.00% | n/a | 8.60% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Bhagyanagar India Ltd | BHAGYANGR | Copper | 106.49 | 3.41B | -2.42% | 34.15 | 52.08% |
Touchwood Entertainment Limited | TOUCHWOOD | Advertising Agencies | 172.05 | 1.91B | 1.72% | 49.20 | 4.88% |
Cubex Tubings Limited | CUBEXTUB | Copper | 96.65 | 1.38B | -1.91% | 34.07 | 21.78% |
Madhav Copper Limited | MCL | Copper | 36.91 | 1.03B | -1.89% | n/a | 32.70% |
Heads UP Ventures Limited | HEADSUP | Apparel Retail | 14.89 | 336.84M | -5.34% | n/a | 0.00% |
Suumaya Industries Limited | SUULD | Apparel Retail | 5.05 | 303.87M | -0.98% | n/a | -118.72% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 32.20 | - | Expensive |
Ent. to Revenue | 2.98 | - | Cheaper |
PE Ratio | - | 47.84 | - |
Price to Book | 3.89 | 6.55 | Cheaper |
Dividend Yield | 0.26 | - | Poor |
Std. Deviation (3M) | 47.80 | - | Par |
Debt to Equity | 1.20 | 0.34 | Expensive |
Debt to Assets | 0.43 | 0.17 | Expensive |
Market Cap | 10.70B | - | Emerging |